ACES - ACE inhibitors Combined with Exercise for hypertensive Seniors
ACES - ACE inhibitors Combined with Exercise for hypertensive Seniors
批准号:
10670590
负责人:
Thomas W Buford
金额:
$51.55万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-15 至 2023-05-31
关键词:
AdjuvantAerobic ExerciseAmericanAngiotensin-Converting Enzyme InhibitorsAntihypertensive AgentsAttenuatedBlood PressureBlood capillariesCardiac Surgery proceduresCardiovascular systemCessation of lifeCholesterolChronicCitiesClinicalClinical Practice GuidelineDataDoseDrug PrescriptionsDual-Energy X-Ray AbsorptiometryE-SelectinElderlyEndocrineEpidemiologyEventExerciseFDA approvedGait speedGeographyGlucoseHeartHydrochlorothiazideHypertensionIndividualInflammationInterleukin-6InterventionIntervention StudiesLife StyleLosartanMasksMeasuresMessenger RNAMuscleMuscle FibersOutcomeOxidative RegulationOxidative StressParticipantPerindoprilPharmaceutical PreparationsPharmacologyPhasePhysical ExercisePhysical PerformancePhysiologicalPopulationProteinsProtocols documentationRandomizedRandomized Clinical TrialsRandomized Controlled TrialsRenin-Angiotensin SystemReportingRiskRisk ReductionSignal TransductionSiteSkeletal MuscleStructureTNF geneTarget PopulationsTestingThiazide DiureticsVascular Cell Adhesion Molecule-1Walkingangiogenesisantagonistbaseblood pressure controlcardiovascular healthcardiovascular risk factorclinical practiceclinically relevantclinically significantdisabilityexercise capacityexercise interventionexercise programexercise trainingexperiencefunctional declinefunctional improvementfunctional outcomesfunctional statushigh riskhigh risk populationhypertensiveimprovedindexingmembernormotensiveoxidized low density lipoproteinpeerpre-clinicalpreservationpreventprimary outcomepublic health prioritiespublic health relevancereceptorrecruitresponsesafety and feasibilitysecondary outcomesedentarysurgical risksystemic inflammatory responsevascular inflammationwalking speed
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The purpose of this project is to conduct a randomized, controlled trial (RCT) to determine if choice of
antihypertensive medication influences changes in functional status and other cardiovascular risk factors
among older persons with hypertension. Functional status, determined by measures of physical performance,
is an important predictor of cardiovascular outcomes in older adults. Seniors with compromised function
experience more CV events, have a higher risk of undergoing cardiac surgery and higher risk of CVD-related
death than higher-functioning peers. Seniors with hypertension experience accelerated declines in function,
and presently physical exercise is the primary strategy for preventing this decline. However, functional
responses to exercise are highly variable and appear to be influenced by the type of antihypertensive
medication(s) utilized to control blood pressure. Preliminary evidence suggests that, compared to other first-
line antihypertensive agents, angiotensin converting enzyme (ACE) inhibitors enhance exercise-derived
improvements in functional status among hypertensive seniors. This RCT will test this hypothesis. Sedentary
older adults with functional limitations and hypertension will be recruited from two sites to participate in a
randomized clinical trial in which they will be randomly assigned to one of three first-line antihypertensive
agents: (1) the ACE inhibitor perindopril, (2) AT1 receptor antagonist losartan, or (3) the thiazide diuretic
hydrochlorothiazide. All participants will also participate in a structured aerobic exercise intervention. This trial
will evaluate whether, compared to losartan and HCTZ, perindopril improves indices of functional status and
cardiovascular risk when combined with physical exercise. This study is expected to differentiate beneficial
effects of three FDA-approved antihypertensive medications on an emerging cardiovascular risk factor in a
clinically-relevant population. Thus the study has important implications for expeditiously influencing clinical
practice guidelines in the prescription of antihypertensive drugs to millions of Americans.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
ANG1-7 as an intervention for Alzheimer's Disease.
-
批准号:10592577
-
项目类别:
-
资助金额:$19.66万
-
财政年份:2023
-
负责人:Thomas W Buford
-
依托单位:
The Exercise and Physical Activity Collaborative Team (ExPACT): a Proposed MoTrPAC Clinical Center
-
批准号:10893749
-
项目类别:
-
资助金额:$9.78万
-
财政年份:2023
-
负责人:Thomas W Buford
-
依托单位:
Interconnections among Cognition, Pain, and Physical Function in Aging.
-
批准号:10224654
-
项目类别:
-
资助金额:$10.49万
-
财政年份:2020
-
负责人:Thomas W Buford
-
依托单位:
Interconnections among Cognition, Pain, and Physical Function in Aging.
-
批准号:10679022
-
项目类别:
-
资助金额:$10.49万
-
财政年份:2020
-
负责人:Thomas W Buford
-
依托单位:
Interconnections among Cognition, Pain, and Physical Function in Aging.
-
批准号:10409792
-
项目类别:
-
资助金额:$10.49万
-
财政年份:2020
-
负责人:Thomas W Buford
-
依托单位:
Interconnections among Cognition, Pain, and Physical Function in Aging.
-
批准号:9889349
-
项目类别:
-
资助金额:$10.49万
-
财政年份:2020
-
负责人:Thomas W Buford
-
依托单位:
ACE2 as a novel therapeutic to preserve physical function in late life
-
批准号:9323124
-
项目类别:
-
资助金额:$30.44万
-
财政年份:2017
-
负责人:Thomas W Buford
-
依托单位:
ACE2 as a novel therapeutic to preserve physical function in late life
-
批准号:10163758
-
项目类别:
-
资助金额:$21.31万
-
财政年份:2017
-
负责人:Thomas W Buford
-
依托单位:
ACE2 as a novel therapeutic to preserve physical function in late life
-
批准号:9927966
-
项目类别:
-
资助金额:$30.44万
-
财政年份:2017
-
负责人:Thomas W Buford
-
依托单位:
ACE2 as a novel therapeutic to preserve physical function in late life
-
批准号:9813211
-
项目类别:
-
资助金额:$6.35万
-
财政年份:2017
-
负责人:Thomas W Buford
-
依托单位:
ACES - ACE inhibitors Combined with Exercise for hypertensive Seniors
-
批准号:10228615
-
项目类别:
-
资助金额:$56.26万
-
财政年份:2017
-
负责人:Thomas W Buford
-
依托单位:
ACES - ACE inhibitors Combined with Exercise for hypertensive Seniors
-
批准号:9980747
-
项目类别:
-
资助金额:$57.31万
-
财政年份:2017
-
负责人:Thomas W Buford
-
依托单位:
ACES - ACE inhibitors Combined with Exercise for hypertensive Seniors
-
批准号:9366565
-
项目类别:
-
资助金额:$56.72万
-
财政年份:2017
-
负责人:Thomas W Buford
-
依托单位:
The Exercise and Physical Activity Collaborative Team (ExPACT): A MoTrPAC Clinical Center
-
批准号:10839504
-
项目类别:
-
资助金额:$205.46万
-
财政年份:2016
-
负责人:Thomas W Buford
-
依托单位:
The Exercise and Physical Activity Collaborative Team (ExPACT): a Proposed MoTrPAC Clinical Center
-
批准号:10326390
-
项目类别:
-
资助金额:$237.5万
-
财政年份:2016
-
负责人:Thomas W Buford
-
依托单位:
KAATSU Training to Enhance Physical Function of Older Adults with Osteoarthritis
-
批准号:8874909
-
项目类别:
-
资助金额:$16.5万
-
财政年份:2014
-
负责人:Thomas W Buford
-
依托单位:
KAATSU Training to Enhance Physical Function of Older Adults with Osteoarthritis
-
批准号:8692139
-
项目类别:
-
资助金额:$19.8万
-
财政年份:2014
-
负责人:Thomas W Buford
-
依托单位:
Interdisciplinary Training in Pathobiology and Rehabilitation Medicine
-
批准号:10176169
-
项目类别:
-
资助金额:$38.4万
-
财政年份:2012
-
负责人:Thomas W Buford
-
依托单位:
Interdisciplinary Training in Pathobiology and Rehabilitation Medicine.
-
批准号:10623981
-
项目类别:
-
资助金额:$40.28万
-
财政年份:2012
-
负责人:Thomas W Buford
-
依托单位:
Interdisciplinary Training in Pathobiology and Rehabilitation Medicine
-
批准号:9922132
-
项目类别:
-
资助金额:$33.43万
-
财政年份:2012
-
负责人:Thomas W Buford
-
依托单位:
海外基金